Grand Pharmaceutical Group Limited (HKG:0512)

HKG:0512 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,474	16,809	14,394	16,225	22,930	24,421
Market Cap Growth	74.60%	16.78%	-11.29%	-29.24%	-6.11%	70.53%
Enterprise Value	28,884	18,299	16,581	18,124	22,786	25,877
Last Close Price	7.56	4.59	3.71	4.04	5.53	5.81
PE Ratio	12.72	6.81	7.66	7.80	9.54	13.62
Forward PE	12.50	8.11	7.31	7.90	9.61	15.87
PS Ratio	2.26	1.44	1.37	1.70	2.67	3.84
PB Ratio	1.53	1.02	0.94	1.14	1.71	2.15
P/TBV Ratio	2.10	1.28	1.12	1.34	1.95	2.48
P/FCF Ratio	22.33	12.52	7.43	13.34	14.95	19.59
P/OCF Ratio	15.15	8.86	5.94	8.81	11.43	16.77
EV/Sales Ratio	2.47	1.57	1.58	1.90	2.65	4.07
EV/EBITDA Ratio	10.74	6.84	5.16	5.83	9.14	12.59
EV/EBIT Ratio	13.44	8.24	5.80	6.60	10.50	14.51
EV/FCF Ratio	24.36	13.63	8.56	14.90	14.85	20.75
Debt / Equity Ratio	0.27	0.27	0.22	0.32	0.27	0.22
Debt / EBITDA Ratio	1.84	1.63	1.05	1.42	1.46	1.18
Debt / FCF Ratio	3.89	3.31	1.76	3.68	2.38	1.96
Asset Turnover	0.46	0.49	0.47	0.44	0.45	0.41
Inventory Turnover	3.66	3.56	2.94	2.94	3.23	2.62
Quick Ratio	0.99	1.01	0.98	0.86	1.00	1.00
Current Ratio	1.20	1.22	1.22	1.07	1.22	1.24
Return on Equity (ROE)	12.37%	15.51%	12.86%	15.18%	19.41%	17.94%
Return on Assets (ROA)	4.77%	5.84%	7.96%	7.91%	7.13%	7.24%
Return on Invested Capital (ROIC)	8.69%	11.77%	15.04%	15.83%	15.13%	14.83%
Return on Capital Employed (ROCE)	9.90%	12.10%	17.00%	17.30%	14.00%	14.10%
Earnings Yield	7.85%	14.69%	13.06%	12.82%	10.48%	7.34%
FCF Yield	4.48%	7.99%	13.46%	7.50%	6.69%	5.11%
Dividend Yield	3.44%	5.67%	7.01%	3.46%	1.99%	1.89%
Payout Ratio	43.19%	36.88%	26.43%	18.78%	16.25%	18.09%
Buyback Yield / Dilution	-0.13%	0.17%	0.97%	0.16%	-2.98%	-2.19%
Total Shareholder Return	3.31%	5.83%	7.99%	3.62%	-1.00%	-0.30%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.